Elke Bouwens, Alexander Vanmaele, Sanne E Hoeks, Hence Jm Verhagen, Bram Fioole, Adriaan Moelker, Sander Ten Raa, Burhan Hussain, José Oliveira-Pinto, Frederico Bastos Gonçalves, Arne S Ijpma, Imo E Hoefer, Felix van Lier, K Martijn Akkerhuis, Danielle F Majoor-Krakauer, Eric Boersma, Isabella Kardys
BACKGROUND: Surveillance programs in abdominal aortic aneurysms (AAA) are mainly based on imaging and leave room for improvement to timely identify patients at risk for AAA growth. Many biomarkers are dysregulated in patients with AAA, which fuels interest in biomarkers as indicators of disease progression. We examined associations of 92 cardiovascular disease (CVD)-related circulating biomarkers with AAA and sac volume. METHODS: In a cross-sectional analysis, we separately investigated (1) 110 watchful waiting (WW) patients (undergoing periodic surveillance imaging without planned intervention) and (2) 203 patients after endovascular aneurysm repair (EVAR)...
July 3, 2023: Vascular Medicine